FSB Premier Wealth Management Inc. Has $1.79 Million Stock Position in Elevance Health, Inc. $ELV

FSB Premier Wealth Management Inc. grew its holdings in Elevance Health, Inc. (NYSE:ELV) by 41.1% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,548 shares of the company’s stock after purchasing an additional 1,615 shares during the period. FSB Premier Wealth Management Inc.’s holdings in Elevance Health were worth $1,793,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Canoe Financial LP increased its position in shares of Elevance Health by 18.1% during the 3rd quarter. Canoe Financial LP now owns 389,399 shares of the company’s stock worth $125,823,000 after purchasing an additional 59,743 shares during the last quarter. Synergy Asset Management LLC grew its stake in shares of Elevance Health by 100.0% in the third quarter. Synergy Asset Management LLC now owns 104,334 shares of the company’s stock valued at $33,712,000 after buying an additional 52,167 shares in the last quarter. Delta Investment Management LLC acquired a new position in Elevance Health during the third quarter worth $7,629,000. Verdence Capital Advisors LLC raised its position in Elevance Health by 3.9% during the second quarter. Verdence Capital Advisors LLC now owns 21,213 shares of the company’s stock worth $8,251,000 after acquiring an additional 790 shares in the last quarter. Finally, OLD National Bancorp IN raised its position in Elevance Health by 44.8% during the second quarter. OLD National Bancorp IN now owns 6,267 shares of the company’s stock worth $2,438,000 after acquiring an additional 1,939 shares in the last quarter. Institutional investors own 89.24% of the company’s stock.

Elevance Health Trading Down 0.4%

Shares of NYSE:ELV opened at $370.77 on Friday. Elevance Health, Inc. has a 12-month low of $273.71 and a 12-month high of $458.75. The business has a 50 day moving average of $349.17 and a 200-day moving average of $328.79. The company has a quick ratio of 1.56, a current ratio of 1.56 and a debt-to-equity ratio of 0.71. The stock has a market cap of $82.40 billion, a PE ratio of 15.16, a P/E/G ratio of 1.91 and a beta of 0.51.

Analyst Upgrades and Downgrades

ELV has been the topic of several recent analyst reports. The Goldman Sachs Group started coverage on shares of Elevance Health in a research note on Tuesday, October 14th. They set a “neutral” rating and a $343.00 price objective on the stock. Mizuho set a $413.00 price target on Elevance Health in a report on Friday, January 9th. Wolfe Research set a $425.00 price objective on Elevance Health and gave the company an “outperform” rating in a research note on Thursday, January 8th. Weiss Ratings upgraded Elevance Health from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, January 12th. Finally, Barclays boosted their target price on Elevance Health from $385.00 to $404.00 and gave the stock an “overweight” rating in a report on Monday, January 5th. Twelve research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $399.63.

Elevance Health Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.